These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5760695)

  • 1. [On the prevention of feto-maternal erythrocytic transfusions with citrobioflavonoids and ascorbic acid in homo-specific pregnancies].
    Misurale F; Spensieri S; Carnevale-Arella E; Storace A
    Ann Ostet Ginecol Med Perinat; 1968 Mar; 90(3):165-80. PubMed ID: 5760695
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of citroflavonoids in the prevention of complications due to fetomaternal blood incompatibility].
    Garès R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(3):288-90. PubMed ID: 5962895
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of feto-maternal Rh isoimmunization].
    Gómez Piña de la Peza ; Lamadrid Montemayor F; Flores Rodríguez JJ
    Ginecol Obstet Mex; 1971 Jan; 29(171):99-104. PubMed ID: 4996660
    [No Abstract]   [Full Text] [Related]  

  • 4. The management of large Rh o (D) incompatible feto-maternal bleedings with anti-Rh o (D) immunoglobulins.
    Vermylen C
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):451. PubMed ID: 5526985
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis and treatment of blood coagulation disorders in pregnant women].
    Domanova AI
    Pediatr Akus Ginekol; 1967; 1():47-9. PubMed ID: 5621148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Feto-maternal transfusion following cordocentesis].
    Sikovanyecz J; Nyári T; Faragó M; Sallay E; Gellén J; Szabó J
    Orv Hetil; 1998 Aug; 139(35):2059-64. PubMed ID: 9755624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Massive feto-maternal hemorrhage and prevention of Rhesus feto-maternal incompatibility].
    Quartier P; Floch C; Meir F; Fruchart MF; Brossard Y; Lejeune C
    Arch Fr Pediatr; 1993 Feb; 50(2):175-6. PubMed ID: 8343031
    [No Abstract]   [Full Text] [Related]  

  • 8. Placental drainage of fetal blood at cesarean delivery and feto maternal transfusion: a randomized controlled trial.
    Leavitt BG; Huff DL; Bell LA; Thurnau GR
    Obstet Gynecol; 2007 Sep; 110(3):608-11. PubMed ID: 17766607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fetomaternal blood immunization. Screening, prevention].
    Poissonnier MH
    Rev Prat; 2000 May; 50(9):1029-34. PubMed ID: 10865505
    [No Abstract]   [Full Text] [Related]  

  • 10. Feto-maternal transfusion in normal pregnancy and during delivery.
    Choavaratana R; Uer-Areewong S; Makanantakosol S
    J Med Assoc Thai; 1997 Feb; 80(2):96-100. PubMed ID: 9078693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the use of vitamins P and C for the prevention of increased capillary fragility in children].
    Kucher AG
    Vopr Pitan; 1966; 25(2):39-42. PubMed ID: 5998319
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of third stage of labour, with particular reference to reduction of feto-maternal transfusion.
    Ladipo OA
    Br Med J; 1972 Mar; 1(5802):721-3. PubMed ID: 5015327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A management of the third stage to reduce feto-maternal transfusion.
    Terry MF
    J Obstet Gynaecol Br Commonw; 1970 Feb; 77(2):129-32. PubMed ID: 4986844
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vitamin C and P requirements of pregnant women endangered by hemorrhage during labor in the city of Frunze].
    Paleĭ MA
    Sov Zdravookhr Kirg; 1970; 2():38-40. PubMed ID: 4246949
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical aspects of the combination of hesperidin & ascorbic acid].
    LOPEZ MERINO V
    Med Esp; 1958 Jun; 39(231):511-8. PubMed ID: 13577246
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution to the treatment of capillary fragility with ascorbic acid and rutin].
    JOBE H
    Praxis; 1954 Feb; 43(7):139-45. PubMed ID: 13145475
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment and prevention of cerebral arterial disorders in aged and of their consequences. Rheoencephalographic examinations].
    Albot G; Goutmer B; Treps J
    Therapeutique; 1971; 47(6):579-84. PubMed ID: 5571174
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of galascorbin on hemodynamics].
    Shamraĭ EF; Lygina TI; Slobodianiuk MI
    Vrach Delo; 1966 May; 5():80-2. PubMed ID: 5995521
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined antihistamine-ascorbic acid-bioflavinoid therapy in urticaria and related dermatoses; a preliminary report.
    FOWLKES RW; TRICE ER
    Va Med Mon (1918); 1957 Aug; 84(8):385-7. PubMed ID: 13456349
    [No Abstract]   [Full Text] [Related]  

  • 20. [Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention].
    Quartier P; Floch C; Meier F; Fruchart MF; Brossard Y; Lejeune C
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):517-9. PubMed ID: 8228016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.